S&P 500   3,352.93 (+0.04%)
DOW   27,551.44 (-0.12%)
QQQ   276.99 (-0.08%)
AAPL   114.98 (+0.02%)
MSFT   209.50 (+0.03%)
FB   260.66 (+1.50%)
GOOGL   1,467.27 (+0.59%)
AMZN   3,186.00 (+0.38%)
TSLA   417.85 (-0.80%)
NVDA   524.85 (+0.66%)
BABA   277.56 (+0.56%)
CGC   14.23 (+0.14%)
MU   50.31 (+1.19%)
GE   6.18 (-0.32%)
AMD   80.85 (+1.72%)
T   28.32 (-0.21%)
F   6.65 (-0.60%)
ACB   4.61 (-3.56%)
GILD   62.73 (-0.19%)
NFLX   492.24 (+0.32%)
DIS   125.50 (-0.39%)
BA   163.63 (-1.48%)
BAC   23.93 (-0.66%)
S&P 500   3,352.93 (+0.04%)
DOW   27,551.44 (-0.12%)
QQQ   276.99 (-0.08%)
AAPL   114.98 (+0.02%)
MSFT   209.50 (+0.03%)
FB   260.66 (+1.50%)
GOOGL   1,467.27 (+0.59%)
AMZN   3,186.00 (+0.38%)
TSLA   417.85 (-0.80%)
NVDA   524.85 (+0.66%)
BABA   277.56 (+0.56%)
CGC   14.23 (+0.14%)
MU   50.31 (+1.19%)
GE   6.18 (-0.32%)
AMD   80.85 (+1.72%)
T   28.32 (-0.21%)
F   6.65 (-0.60%)
ACB   4.61 (-3.56%)
GILD   62.73 (-0.19%)
NFLX   492.24 (+0.32%)
DIS   125.50 (-0.39%)
BA   163.63 (-1.48%)
BAC   23.93 (-0.66%)
S&P 500   3,352.93 (+0.04%)
DOW   27,551.44 (-0.12%)
QQQ   276.99 (-0.08%)
AAPL   114.98 (+0.02%)
MSFT   209.50 (+0.03%)
FB   260.66 (+1.50%)
GOOGL   1,467.27 (+0.59%)
AMZN   3,186.00 (+0.38%)
TSLA   417.85 (-0.80%)
NVDA   524.85 (+0.66%)
BABA   277.56 (+0.56%)
CGC   14.23 (+0.14%)
MU   50.31 (+1.19%)
GE   6.18 (-0.32%)
AMD   80.85 (+1.72%)
T   28.32 (-0.21%)
F   6.65 (-0.60%)
ACB   4.61 (-3.56%)
GILD   62.73 (-0.19%)
NFLX   492.24 (+0.32%)
DIS   125.50 (-0.39%)
BA   163.63 (-1.48%)
BAC   23.93 (-0.66%)
S&P 500   3,352.93 (+0.04%)
DOW   27,551.44 (-0.12%)
QQQ   276.99 (-0.08%)
AAPL   114.98 (+0.02%)
MSFT   209.50 (+0.03%)
FB   260.66 (+1.50%)
GOOGL   1,467.27 (+0.59%)
AMZN   3,186.00 (+0.38%)
TSLA   417.85 (-0.80%)
NVDA   524.85 (+0.66%)
BABA   277.56 (+0.56%)
CGC   14.23 (+0.14%)
MU   50.31 (+1.19%)
GE   6.18 (-0.32%)
AMD   80.85 (+1.72%)
T   28.32 (-0.21%)
F   6.65 (-0.60%)
ACB   4.61 (-3.56%)
GILD   62.73 (-0.19%)
NFLX   492.24 (+0.32%)
DIS   125.50 (-0.39%)
BA   163.63 (-1.48%)
BAC   23.93 (-0.66%)
Log in
NASDAQ:APDN

Applied DNA Sciences Stock Forecast, Price & News

$8.83
+0.49 (+5.88 %)
(As of 09/29/2020 09:40 AM ET)
Add
Compare
Today's Range
$8.26
Now: $8.83
$8.83
50-Day Range
$7.30
MA: $8.35
$10.00
52-Week Range
$2.52
Now: $8.83
$19.69
Volume3,200 shs
Average Volume1.29 million shs
Market Capitalization$45.41 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23
Applied DNA Sciences, Inc. develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, Smart DNA, and Backtrac that are molecular tags to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high-value assets through inks, varnishes, and coatings; and SigNify IF portable DNA readers that provides real-time authentication of molecular tags. In addition, the company offers Applied DNA Sciences Portal, a software platform that enables customers to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems and Cannabis Tracking System, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Additionally, the company offers contract research services for the nucleic acid-based medical and biologic markets; and various RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Read More
Applied DNA Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous business services
Sub-IndustryN/A
Current SymbolNASDAQ:APDN
CUSIPN/A
Phone631-840-8800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.39 million
Book Value($0.71) per share

Profitability

Net Income$-8,620,000.00
Net Margins-304.46%

Miscellaneous

Employees59
Market Cap$45.41 million
Next Earnings Date12/10/2020 (Estimated)
OptionableOptionable
$8.83
+0.49 (+5.88 %)
(As of 09/29/2020 09:40 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

How has Applied DNA Sciences' stock price been impacted by Coronavirus (COVID-19)?

Applied DNA Sciences' stock was trading at $4.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, APDN stock has increased by 115.4% and is now trading at $8.83.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Applied DNA Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Applied DNA Sciences
.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release its next quarterly earnings announcement on Thursday, December 10th 2020.
View our earnings forecast for Applied DNA Sciences
.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences Inc (NASDAQ:APDN) issued its quarterly earnings results on Thursday, August, 6th. The technology company reported ($0.72) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.62) by $0.10. The technology company had revenue of $0.43 million for the quarter, compared to the consensus estimate of $0.50 million. Applied DNA Sciences had a negative net margin of 304.46% and a negative return on equity of 180.24%.
View Applied DNA Sciences' earnings history
.

What price target have analysts set for APDN?

2 brokerages have issued 12-month target prices for Applied DNA Sciences' stock. Their forecasts range from $21.00 to $22.00. On average, they expect Applied DNA Sciences' share price to reach $21.50 in the next year. This suggests a possible upside of 143.5% from the stock's current price.
View analysts' price targets for Applied DNA Sciences
.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 450,300 shares, a decrease of 18.6% from the August 31st total of 553,000 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is currently 0.4 days. Currently, 10.3% of the company's stock are sold short.
View Applied DNA Sciences' Short Interest
.

Who are some of Applied DNA Sciences' key competitors?

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Advanced Micro Devices (AMD), Inovio Pharmaceuticals (INO), Ekso Bionics (EKSO), Arbutus Biopharma (ABUS), Micron Technology (MU), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the following people:
  • Dr. James A. Hayward Ph.D., Sc.D., Pres, CEO & Chairman (Age 65)
  • Ms. Beth M. Jantzen CPA, CPA, Chief Financial Officer (Age 43)
  • Ms. Judith Murrah, Chief Information Officer & Sec. (Age 61)
  • Mr. Clay Shorrock Esq., Gen. Counsel
  • Mr. Tony Benson, Managing Director of EMEA

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $8.83.

How big of a company is Applied DNA Sciences?

Applied DNA Sciences has a market capitalization of $45.41 million and generates $5.39 million in revenue each year. The technology company earns $-8,620,000.00 in net income (profit) each year or ($10.46) on an earnings per share basis. Applied DNA Sciences employs 59 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is www.adnas.com.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.